Keyphrases
Rheumatoid Arthritis
100%
Hospitalization Risk
100%
Disease-modifying Antirheumatic Drugs (DMARDs)
100%
Vaccination Status
100%
COVID-19 Hospitalization
100%
COVID-19 Infection Risk
100%
Unvaccinated
66%
Incidence Rate
50%
RA Patients
33%
COVID-19 Incidence
33%
Vaccinated Patients
33%
Confidence Interval
16%
Adjusted Hazard Ratio
16%
Comorbidity
16%
Matched Cohort Study
16%
Cox Model
16%
Danish National Patient Registry
16%
Rituximab
16%
Cause-specific
16%
PCR Test
16%
Benefits of Vaccination
16%
Crude Incidence Rate
16%
Conventional DMARDs
16%
Relative Benefit
16%
Fully Vaccinated
16%
COVID-19
16%
SARS-CoV-2 PCR
16%
COVID-19 Surveillance
16%
Nursing and Health Professions
Infection
100%
Rheumatoid Arthritis
100%
Vaccination Policy
100%
Severe Acute Respiratory Syndrome
50%
Comorbidity
25%
Population
25%
Confidence Interval
25%
Cohort Analysis
25%
Hazard Ratio
25%
Proportional Hazards Model
25%
Rituximab
25%
Medicine and Dentistry
Infection
100%
Rheumatoid Arthritis
100%
Disease-Modifying Antirheumatic Drug
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Population
14%
Cohort Analysis
14%
Hazard Ratio
14%
Proportional Hazards Model
14%
Polymerase Chain Reaction
14%
Rituximab
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Vaccination Policy
100%
Infection
100%
SARS Coronavirus
50%
Cohort Study
25%
Comorbidity
25%
Rituximab
25%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Population
50%
Cohort Study
50%
Comorbidity
50%
Polymerase Chain Reaction
50%
Rituximab
50%